Matthew Koshy to Hematologic Neoplasms
This is a "connection" page, showing publications Matthew Koshy has written about Hematologic Neoplasms.
Connection Strength
0.090
-
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41.
Score: 0.090